Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.

NCT06857747 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Capecitabine
DRUG: Vinorelbine
DRUG: Etoposide

Sponsor

QIAO LI